NYSE:CMAComerica Stock Price, Forecast & News

Comerica's stock was trading at $38.03 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CMA shares have decreased by 5.3% and is now trading at $36.00. View which stocks have been most impacted by Coronavirus.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Comerica in the last year. There are currently 5 sell ratings, 13 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Comerica.

Comerica is scheduled to release its next quarterly earnings announcement on Tuesday, July 21st 2020. View our earnings forecast for Comerica.

Comerica will be holding an earnings conference call on Tuesday, July 21st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Comerica Incorporated (NYSE:CMA) posted its earnings results on Tuesday, April, 21st. The financial services provider reported ($0.46) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.95 by $1.41. The financial services provider had revenue of $750 million for the quarter, compared to analyst estimates of $752.26 million. Comerica had a net margin of 21.37% and a return on equity of 10.77%. During the same quarter in the previous year, the company earned $2.11 earnings per share. View Comerica's earnings history.

Comerica declared a quarterly dividend on Tuesday, April 28th. Stockholders of record on Monday, June 15th will be given a dividend of $0.68 per share on Wednesday, July 1st. This represents a $2.72 annualized dividend and a dividend yield of 7.56%. The ex-dividend date is Friday, June 12th. View Comerica's dividend history.

Comerica announced that its board has initiated a share buyback plan on Tuesday, January 22nd 2019, which permits the company to repurchase 15,000,000 shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company's management believes its stock is undervalued.

22 equities research analysts have issued 12-month target prices for Comerica's shares. Their forecasts range from $26.00 to $72.50. On average, they anticipate Comerica's stock price to reach $46.13 in the next year. This suggests a possible upside of 28.1% from the stock's current price. View analysts' price targets for Comerica.

News stories about CMA stock have trended very negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Comerica earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned media coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Comerica.

Some companies that are related to Comerica include BANCO DO BRASIL/S (BDORY), Standard Chartered (SCBFF), DANSKE BK A/S/S (DNKEY), Shinhan Financial Group (SHG), KeyCorp (KEY), Regions Financial (RF), Huntington Bancshares (HBAN), Zions Bancorporation NA (ZION), Akbank T.A.S. (AKBTY), Cullen/Frost Bankers (CFR), TCF Financial (TCF), BOK Financial (BOKF), Pinnacle Financial Partners (PNFP), Valley National Bancorp (VLY) and Synovus Financial (SNV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Comerica investors own include NVIDIA (NVDA), Bank of America (BAC), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), AT&T (T), Skyworks Solutions (SWKS), General Electric (GE), Applied Materials (AMAT), Honda Motor (HMC) and Mcdonald's (MCD).

Comerica trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMA."

Comerica's stock is owned by a number of retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.03%), DNB Asset Management AS (0.02%), Fourthstone LLC (0.01%), IFM Investors Pty Ltd (0.01%), Louisiana State Employees Retirement System (0.00%) and Gradient Investments LLC (0.00%). Company insiders that own Comerica stock include Christine M Moore, Hardy Matthew, James Harry Weber, Megan D Burkhart, Paul R Obermeyer, Peter William Guilfoile and Reginald M Turner, Jr. View institutional ownership trends for Comerica.

CMA stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., DNB Asset Management AS, IFM Investors Pty Ltd, and NuWave Investment Management LLC. Company insiders that have sold Comerica company stock in the last year include James Harry Weber, Peter William Guilfoile, and Reginald M Turner, Jr. View insider buying and selling activity for Comerica.

CMA stock was acquired by a variety of institutional investors in the last quarter, including Fourthstone LLC, Louisiana State Employees Retirement System, Gradient Investments LLC, and Ellevest Inc.. View insider buying and selling activity for Comerica.

Shares of CMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CMA stock can currently be purchased for approximately $36.00.

Comerica has a market capitalization of $5.01 billion and generates $3.82 billion in revenue each year. The financial services provider earns $1.20 billion in net income (profit) each year or $7.81 on an earnings per share basis. Comerica employs 7,948 workers across the globe.

The official website for Comerica is www.comerica.com.

Comerica's mailing address is 1717 MAIN STREET MC6404, DALLAS TX, 75201. The financial services provider can be reached via phone at 214-462-6831 or via email at [email protected]